Vanak Eye Surgery Center

Quick facts

Phase 3 pipeline

• Subconjunctival Avastin · Ophthalmology
  Avastin (bevacizumab) inhibits vascular endothelial growth factor (VEGF) to reduce abnormal blood vessel formation and leakage in the eye.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vanak Eye Surgery Center portfolio CI brief
• Vanak Eye Surgery Center pipeline updates RSS